These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29642620)

  • 21. Anthocyanin extracted from black soybean reduces prostate weight and promotes apoptosis in the prostatic hyperplasia-induced rat model.
    Jang H; Ha US; Kim SJ; Yoon BI; Han DS; Yuk SM; Kim SW
    J Agric Food Chem; 2010 Dec; 58(24):12686-91. PubMed ID: 21121678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo.
    Park E; Lee MY; Jeon WY; Seo CS; You S; Shin HK
    J Ethnopharmacol; 2018 May; 218():109-115. PubMed ID: 29501675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of telmisartan in the treatment of benign prostatic hyperplasia.
    Ishola IO; Anunobi CC; Tijani KH; Afolayan O; Udokwu VU
    Fundam Clin Pharmacol; 2017 Dec; 31(6):643-651. PubMed ID: 28727906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sorghum ethyl-acetate extract on benign prostatic hyperplasia induced by testosterone in Sprague-Dawley rats.
    Ryu JM; Jang GY; Park D; Woo KS; Kim TM; Jeong HS; Kim DJ
    Biosci Biotechnol Biochem; 2018 Dec; 82(12):2101-2108. PubMed ID: 30124113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of seahorse extracts in a rat castration and testosterone-induced benign prostatic hyperplasia model and mouse oligospermatism model.
    Xu DH; Wang LH; Mei XT; Li BJ; Lv JL; Xu SB
    Environ Toxicol Pharmacol; 2014 Mar; 37(2):679-88. PubMed ID: 24607683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
    Mostafa F; Mantawy EM; Azab SS; El-Demerdash E
    Eur J Pharmacol; 2019 Dec; 865():172729. PubMed ID: 31605676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty Acids in Some Cooking Oils as Agents of Hormonal Manipulation in a Rat Model of Benign Prostate Cancer.
    Oyelowo O; Okafor C; Ajibare A; Ayomide B; Dada K; Adelakun R; Ahmed B
    Niger J Physiol Sci; 2019 Jun; 34(1):69-75. PubMed ID: 31449274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triptolide reduces prostate size and androgen level on testosterone-induced benign prostatic hyperplasia in Sprague Dawley rats.
    Wang YR; Xu Y; Jiang ZZ; Zhang LY; Wang T
    Chin J Nat Med; 2017 May; 15(5):341-346. PubMed ID: 28558869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats.
    Kim CY; Chung KS; Cheon SY; Lee JH; Park YB; An HJ
    J Med Food; 2016 Aug; 19(8):746-54. PubMed ID: 27441629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.
    Rick FG; Schally AV; Block NL; Halmos G; Perez R; Fernandez JB; Vidaurre I; Szalontay L
    Prostate; 2011 May; 71(7):736-47. PubMed ID: 20945403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of D-004, a lipid extract from Cuban royal palm fruit, on histological changes of prostate hyperplasia induced with testosterone in rats.
    Noa M; Arruzazabala ML; Carbajal D; Más R; Molina V
    Int J Tissue React; 2005; 27(4):203-11. PubMed ID: 16440586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by reducing expression of androgen receptor and 5α-reductase in a rat model.
    Fang T; Xue ZS; Li JX; Liu JK; Wu D; Li MQ; Song YT; Yun SF; Yan J
    J Integr Med; 2021 May; 19(3):258-264. PubMed ID: 33341427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive effects of D-004, a lipid extract from Cuban royal palm (Roystonea regia) fruits, on testosterone-induced prostate hyperplasia in intact and castrated rodents.
    Arruzazabala ML; Carbajal D; Más R; Molina V; Rodríguez E; González V
    Drugs Exp Clin Res; 2004; 30(5-6):227-33. PubMed ID: 15700750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
    Sayed RH; Saad MA; El-Sahar AE
    Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photothermal therapeutic potency of plasmonic silver nanoparticles for apoptosis and anti-angiogenesis in testosterone induced benign prostate hyperplasia in rats.
    Marghani BH; Fehaid A; Ateya AI; Ezz MA; Saleh RM
    Life Sci; 2022 Feb; 291():120240. PubMed ID: 34942164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia.
    Cordaro M; Impellizzeri D; Siracusa R; Gugliandolo E; Fusco R; Inferrera A; Esposito E; Di Paola R; Cuzzocrea S
    Toxicol Appl Pharmacol; 2017 Aug; 329():231-240. PubMed ID: 28610993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bee venom suppresses testosterone-induced benign prostatic hyperplasia by regulating the inflammatory response and apoptosis.
    Chung KS; An HJ; Cheon SY; Kwon KR; Lee KH
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1656-63. PubMed ID: 26085572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis.
    Zheng H; Xu W; Lin J; Peng J; Hong Z
    Mol Med Rep; 2013 Mar; 7(3):848-54. PubMed ID: 23314795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential repositioning of GV1001 as a therapeutic agent for testosterone‑induced benign prostatic hyperplasia.
    Kim KS; Yang HY; Chang SC; Kim YM; Lee KY; Lee BM; Kim HS
    Int J Mol Med; 2018 Oct; 42(4):2260-2268. PubMed ID: 30015834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.